Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 74% ± 13% | |
lung | 18 studies | 75% ± 14% | |
brain | 17 studies | 36% ± 17% | |
intestine | 13 studies | 64% ± 23% | |
eye | 10 studies | 63% ± 24% | |
kidney | 9 studies | 73% ± 16% | |
liver | 7 studies | 60% ± 23% | |
bone marrow | 6 studies | 55% ± 18% | |
lymph node | 6 studies | 75% ± 12% | |
pancreas | 5 studies | 80% ± 19% | |
uterus | 5 studies | 82% ± 19% | |
placenta | 4 studies | 81% ± 19% | |
heart | 4 studies | 34% ± 17% | |
prostate | 4 studies | 73% ± 21% | |
breast | 4 studies | 84% ± 5% | |
adipose | 3 studies | 37% ± 23% | |
adrenal gland | 3 studies | 65% ± 9% | |
esophagus | 3 studies | 72% ± 21% | |
skin | 3 studies | 69% ± 14% | |
thymus | 3 studies | 81% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 12013.03 | 258 / 258 | 100% | 443.04 | 230 / 230 |
brain | 100% | 12080.17 | 2642 / 2642 | 100% | 397.08 | 705 / 705 |
esophagus | 100% | 10499.49 | 1445 / 1445 | 100% | 264.69 | 183 / 183 |
ovary | 100% | 12484.84 | 180 / 180 | 100% | 413.53 | 430 / 430 |
prostate | 100% | 11166.34 | 245 / 245 | 100% | 456.26 | 502 / 502 |
stomach | 100% | 7940.67 | 359 / 359 | 100% | 270.55 | 286 / 286 |
thymus | 100% | 12066.33 | 653 / 653 | 100% | 499.91 | 605 / 605 |
uterus | 100% | 12918.17 | 170 / 170 | 100% | 366.29 | 459 / 459 |
kidney | 100% | 12516.12 | 89 / 89 | 100% | 316.79 | 900 / 901 |
intestine | 100% | 10210.19 | 966 / 966 | 100% | 264.72 | 526 / 527 |
skin | 100% | 8739.99 | 1808 / 1809 | 100% | 360.78 | 471 / 472 |
lung | 100% | 9293.20 | 576 / 578 | 100% | 289.90 | 1155 / 1155 |
liver | 100% | 4944.15 | 225 / 226 | 100% | 252.01 | 406 / 406 |
breast | 100% | 12431.92 | 459 / 459 | 100% | 396.65 | 1113 / 1118 |
bladder | 100% | 10891.86 | 21 / 21 | 99% | 306.09 | 501 / 504 |
pancreas | 99% | 4264.42 | 325 / 328 | 100% | 302.69 | 178 / 178 |
adipose | 100% | 11961.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 12772.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 390.36 | 29 / 29 |
spleen | 100% | 8856.91 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 269.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 204.95 | 1 / 1 |
muscle | 100% | 8052.33 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 9285.61 | 856 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 338.60 | 79 / 80 |
peripheral blood | 91% | 6037.37 | 844 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045047 | Biological process | protein targeting to ER |
GO_0006614 | Biological process | SRP-dependent cotranslational protein targeting to membrane |
GO_0006613 | Biological process | cotranslational protein targeting to membrane |
GO_0005786 | Cellular component | signal recognition particle, endoplasmic reticulum targeting |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0030942 | Molecular function | endoplasmic reticulum signal peptide binding |
GO_0008312 | Molecular function | 7S RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SRP14 |
Protein name | Signal recognition particle 14 kDa protein (SRP14) (18 kDa Alu RNA-binding protein) Signal recognition particle 14 Signal recognition particle 14 kDa protein (SRP14) |
Synonyms | |
Description | FUNCTION: Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) . SRP9 together with SRP14 and the Alu portion of the SRP RNA, constitutes the elongation arrest domain of SRP . The complex of SRP9 and SRP14 is required for SRP RNA binding . . FUNCTION: Component of the signal recognition particle (SRP) complex, a ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER). SRP9 together with SRP14 and the Alu portion of the SRP RNA, constitutes the elongation arrest domain of SRP. The complex of SRP9 and SRP14 is required for SRP RNA binding. . |
Accessions | H0YLA2 H0YLW0 ENST00000559081.1 ENST00000558720.5 ENST00000560773.5 ENST00000267884.11 P37108 |